Where does 4SC AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), 4SC AG ranks #23,746 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does 4SC AG hold?

4SC AG holds 11 US utility patents granted between 2015 and 2025, spanning 5 technology areas.

What is 4SC AG's Innovation Score?

4SC AG has an Innovation Score of 28.4 out of 100 (27th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does 4SC AG focus on?

4SC AG's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 11 patents, ranking #1,740 of 6,058 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is 4SC AG's patent grant rate increasing or decreasing?

4SC AG's recent grant velocity is -57% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for 4SC AG's patents?

4SC AG's patents average 19.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the 4SC AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

4SC AG

USPTO PatentsView assignee record - 11 granted patents across 5 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, 4SC ranks #23,746 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 5 technology areas.

#23,746
of 49,997 US assignees by volume: 27th percentile
by Innovation Score (28.4/100): 19.8
avg claims per patent: -57%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23746 · Foreign Corporation #23,746 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #23,746/49,997
PHOTO-FINISH 3NT Medical
CPC-NARROW A61P · 5 areas
INNOV-THIN 28.4/100
CLAIMS-RICH 19.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -57% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: 3NT Medical Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How 4SC’s 28.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (30%) Velocity 0.0 pts (0%) Breadth 7.9 pts (28%) Claim depth 11.9 pts (42%)

Qualcomm Incorporated · highest

85
4SC · this assignee

28
3D Lighting… · lowest

7

What this shows 4SC's Innovation Score is 28.4/100 (27th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for 4SC?

Each dot is one of 4SC’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). 4SC’s own 19.8 claims/patent is ABOVE the 14.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

4SC vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where 4SC's grants concentrate

4SC AG is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2018 (3 grants) versus a trough of 1 in 2016. By volume, 4SC sits between 3NT Medical Ltd. and 9213-4550 Quebec Inc..

3NT Medical

11
4361423 Canada

11
4iiii Innovations

11
4knines

11
7hugs Labs SAS

11
8 BIT Development

11
8i

11
9213-4550 Quebec

11
4SC ◀

11

What this shows 4SC holds 11 patents at rank #23,746, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near 4SC

By rank, the assignees closest to #23,746 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in 4SC's primary technology class.

4SC's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 27th percentile higher than 27% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

4SC AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	18.2%
2016	1	9.1%
2018	3	27.3%
2019	1	9.1%
2020	3	27.3%
2025partial year	1	9.1%

Which technologies does 4SC AG patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 11

C07D - Heterocyclic Compounds 10

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 10

Y02A - Technologies FOR Adaptation TO Climate Change 3

C07K - Peptides 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

4SC AG's patent record in context - here's where to go next.

4SC AG's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #23,746 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare 4SC AG against 3NT Medical Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.